Blue Owl Capital Holdings LP

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1858703 New York, NY

Position in CGEM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$28,039,102

+$901,356 QoQ

Shares Held

1,539,764

-19.4% QoQ

Ownership

2.39%

of shares outstanding

% of Portfolio

4.27%

of 13F equity value

Holder Rank

#12

of 182 holders

Holding Since

Dec 2023

11 quarters on record

Healthcare · as of Jun 30, 2026

Blue Owl Capital Holdings LP holds $278,984,828 across 30 Biotechnology names. CGEM ranks #2 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AKTS	Aktis Oncology, Inc.	3,070,219	$98,953,158
2	CGEM	Cullinan Therapeutics, Inc. This page	1,539,764	$28,039,102
3	LRMR	Larimar Therapeutics, Inc.	9,163,157	$27,947,628
4	MPLT	MapLight Therapeutics, Inc.	729,929	$26,160,655
5	EYPT	EyePoint, Inc.	762,594	$10,905,094
6	SGMT	Sagimet Biosciences Inc.	1,260,544	$9,744,005
7	CRVS	Corvus Pharmaceuticals, Inc.	608,600	$9,092,484
8	ARTV	Artiva Biotherapeutics, Inc.	874,542	$8,483,057

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,039,102	1,539,764	-19.4%	Shares	Defined	2026-08-11
2026-03-31	$27,137,746	1,909,764	-18.8%	Shares	Defined	2026-05-14
2025-12-31	$24,332,560	2,350,972	-6.4%	Shares	Defined	2026-02-20
2025-09-30	$14,890,063	2,510,972	+5.2%	Shares	Defined	2025-11-12
2025-06-30	$17,966,369	2,385,972	-2.1%	Shares	Defined	2025-08-11
2025-03-31	$18,440,308	2,435,972	+2.7%	Shares	Defined	2025-05-15
2024-12-31	$28,878,438	2,370,972	+17.9%	Shares	Defined	2025-02-14
2024-09-30	$33,663,671	2,010,972	-1.9%	Shares	Defined	2024-11-14
2024-06-30	$35,737,559	2,049,172	-29.9%	Shares	Defined	2024-08-15
2024-03-31	$49,839,307	2,924,842	-14.5%	Shares	Defined	2024-05-15
2023-12-31	$34,848,189	3,419,842	—	Shares	Defined	2024-02-15
No filing history on record for this holder in this stock.